QuantuMDx appoints Chief Commercial Officer

21st January 2021 | QuantuMDx Team

Diran Guiliguian at QuantuMDx

NEWCASTLE UPON TYNE, UK, 21 January 2021. QuantuMDx today announces the appointment of Diran Guiliguian as Chief Commercial Officer.

Diran has over a decade of experience working within world-leading diagnostic and medical device companies. Most recently he was Head of Central Lab Solutions for EMEA at Siemens Healthineers, where he led the introduction of the company’s COVID-19 testing solutions and previously managed its diagnostics business for Southern Europe. Diran has a proven track record of complex product launches and is well versed in successfully executing competitive sales strategies.

Jonathan O’Halloran, Chief Executive Officer of QuantuMDx, said: “Diran’s appointment comes at a critical time for QuantuMDx as we scale up to meet the expected demand for Q-POC™, our rapid, portable PCR device and its SARS-CoV-2 and Flu A & B assay. Diran’s extensive commercial experience will be invaluable to us both in the UK and internationally.”

Commenting on his appointment, Diran Guiliguian, Chief Commercial Officer of QuantuMDx said: “I’m pleased to be joining QuantuMDx at a pivotal stage of its growth. I am impressed with the calibre and energy of the QuantuMDx team, as well as the power that Q-POC™ can bring to diagnostics, not only of COVID-19 but also across infectious diseases. I look forward to making these technologies available across the globe.”


About QuantuMDx:

QuantuMDx Group is an ambitious company with a global vision of empowering the world to control and eradicate disease by making transformative, quality point-of-care diagnostic technologies universally accessible. QuantuMDx has operations and strategic partnerships in the United States, Asia, Australasia, Europe and Africa – keeping it at the forefront of molecular diagnostics. For more information go to: www.quantumdx.com

For media enquiries:

Debra Daglish, Marketing Communications Manager, QuantuMDx Group

Chris Gardner, Matthew Neal and Lindsey Neville, Consilium Strategic Communications, 0203 709 5700/ quantumdx@consilium-comms.com

For investor enquiries:

Financial Adviser: WG Partners LLP; David Wilson (020 3705 9315), Nigel Barnes (020 3705 9318), Claes Spång (020 3705 9317)

For more information:

Please email info@quantumdx.com